Key Highlights
- Shares of Intel closed at $104.47 on Tuesday, representing a 9.05% gain on approximately 140 million shares traded—more than twice the typical daily volume.
- Nvidia’s regulatory filing revealed an approximately $30 billion position in Intel, while SK Hynix is reportedly considering Intel’s foundry operations for HBM4E memory manufacturing.
- The chipmaker successfully completed a $20 billion equity offering priced at $95 per share, expanded from the originally planned $15 billion.
- Industry sources from DigiTimes suggest Intel could implement a CPU price increase of up to 10% in the coming months, marking the third such adjustment in 2026.
- Investment firm Northland Securities elevated Intel to Outperform status with a $120 target, pointing to significant advancement in the company’s transformation strategy.
Intel shares finished Tuesday’s session at $104.47, marking an $8.67 increase for the day. The 9.05% single-day rally occurred on approximately 140 million shares changing hands, representing more than twice the stock’s typical trading activity.
The upward momentum developed in two distinct phases during the trading day.
The initial trigger arrived during morning hours. Intel finalized a $20 billion underwritten equity offering with shares priced at $95 each. The offering size represented an expansion from the initially announced $15 billion target.
Simultaneously, Nvidia’s regulatory filing revealed a position in Intel worth approximately $30 billion. Additionally, industry reports indicated SK Hynix is assessing Intel’s foundry capabilities for potential HBM4E memory chip production.
These three developments collectively pushed the stock higher by multiple percentage points.
Processor Pricing Strategy Powers Afternoon Rally
The stronger momentum arrived during afternoon trading. Industry publication DigiTimes reported that Intel is planning to increase CPU prices by approximately 10% later in 2026, with implementation potentially starting in October.
This would represent Intel’s third pricing adjustment in 2026, following earlier increases during Q1 and in July. While escalating supply-chain expenses are mentioned as justification, the recurring pattern also suggests robust market demand and limited customer migration to alternative suppliers.
On the same day, Northland Securities analyst Gus Richard upgraded Intel to Outperform status, establishing a $120 price objective. His analysis highlighted substantial advancement in Intel’s strategic transformation and foundry business development.
UBS Group similarly elevated Intel from neutral to buy on Tuesday. DA Davidson increased its target from $77 to $100 while maintaining a neutral stance. TD Cowen adjusted its target upward from $75 to $115 with a hold rating.
The Wall Street consensus rating currently stands at Hold, with analysts establishing an average price objective of $107.74.
Leadership and Institutional Investment Activity
Intel CEO Lip-Bu Tan acquired 105,263 shares on August 11th at $95 each, representing approximately $10 million in total investment. This transaction expanded his direct stake by 8.7%, elevating his total holdings to 1,314,669 shares.
TD Waterhouse Canada expanded its Intel holdings by 93.9% during the second quarter, adding 179,187 shares for a total position of 369,989 shares worth approximately $47 million. Institutional ownership now accounts for 64.53% of Intel’s outstanding stock.
Regarding financial performance, Intel delivered Q2 revenue of $16.13 billion, representing a 25.2% year-over-year increase. Earnings per share reached $0.42, substantially exceeding the consensus estimate of $0.21. Intel’s guidance for Q3 2026 EPS stands at $0.38.
Advanced Manufacturing Technology Progress
Intel and ASML jointly announced that Intel Foundry has surpassed one million wafers processed using High-NA EUV technology. This advanced equipment is being deployed for the 18A manufacturing process and forthcoming Panther Lake processor designs.
Mizuho maintains a more conservative outlook, reportedly reducing its price objective to $92 and highlighting dilution considerations stemming from the stock offering and substantial capital requirements for foundry expansion initiatives.
Intel’s 52-week trading range currently extends from $24.05 to $142.35. The present price of $104.47 remains approximately 36% below the 52-week peak.


